$MSCI

MSCI earnings beat by $0.09, revenue topped estimates

MSCI reported Q3 EPS of $5.11, beating estimates by $0.09, with revenue at $892M, exceeding expectations. The stock is up 1.99% in 3 months and 4.28% in 12 months. MSCI's Financial Health score is rated 'good performance' by InvestingPro.

Original reporting
Published Oct 20, 2026, 10:50 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 11:02 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$MSCI
Bullish
high confidence
Mentioned
$MSCI
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$MSCIBullishHigh
01

Why it matters

The earnings beat may prompt analysts to raise price targets and could attract short‑term buying pressure.

02

Market read

Fresh earnings data for a large‑cap index provider offers a timely trading opportunity.

03

What to watch

Guidance outlook and any forward‑looking commentary were not provided, which could limit upside.

Relevance 8/10Novelty 8/10Timing: post‑market today

Background

MSCI is a leading provider of investment decision support tools and ESG indexes. Its quarterly results are closely watched by institutional investors.

Company-level read

Ticker impact

$MSCIBullishHigh confidence
Context

MSCI reported Q3 EPS $5.11, beating estimates by $0.09, and revenue $892M versus $887.8M consensus.

Expected impact

likely upward as the market prices in the earnings beat

Evidence & confidence

The beat on both earnings and revenue for a large‑cap index provider typically triggers buying interest.

Market effects

May boost sentiment for the broader data‑analytics and ESG index space.

U.S. markets could see a modest lift in financial services stocks.

Positive earnings from a global index provider can reinforce confidence in equity market trends worldwide.

Counterpoint

If the beat is already priced in, the stock could face short‑term profit‑taking.

Key entities

  • MSCI Inc.

    Global provider of investment analytics and ESG indexes.

Related articles

$MSCIMed

Raymond James raises MSCI stock price target on strong Q3 results

Raymond James raised its price target for MSCI (NYSE:MSCI) to $680 from $660, citing strong Q3 2026 results. The company reported $892M in revenue and $5.11 EPS, beating estimates. MSCI's growth was driven by its Index, Analytics, and Private Capital Solutions segments. The firm maintains a Strong Buy rating, noting AI-native solutions and long-term revenue growth potential. MSCI trades at a P/E ratio of 32.2 with a $42.7B market cap and 11.6% revenue growth over the last year.

$MSCIMedAI 8/10

What MSCI (MSCI) Said on Its Q3 Earnings Call

MSCI reported Q3 earnings, highlighting 11.7% index subscription growth, 26% custom-index growth, and 19% private capital solutions growth. Analytics grew 7.5%, with LTM net new sales up 18%. AI is a key focus for product innovation. Sustainability segment faced retention pressure, with flat to slightly positive sales expected in Q4. Expenses are expected to be at the high end of 2026 guidance. MSCI repurchased $627M in shares.

$MSCIHighAI 8/10

MSCI Inc. 2026: Revenue $892M, EPS $4.86— 10-Q Summary

MSCI Inc. reported Q3 2026 revenue of $892M, up 12.4% YoY, and EPS of $4.86, up 14.4%. Net income rose 7.9% to $351M. Growth was driven by asset-based fees and subscriptions, with BlackRock as the largest client at 11.8% of revenue. The company invested in product growth and maintained a 95% retention rate.